Prosecution Insights
Last updated: October 25, 2026

Raphael Bellum Pllc: all pending office actions

← Back to Raphael Bellum Pllc

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19568483 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103 Final Rejection — Pending Mar 16, 2026
19413522 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. TRAN, ERIC 1629 §102§112 Non-Final OA — Pending Dec 09, 2025
19407334 REINFORCED SLIDING MITT INCLUDING PROTECTION GUARD WITH TREAD FOR BASEBALL AND SOFTBALL Dynasty Baseball, LLC MORAN, KATHERINE M 3732 §103§112 Non-Final OA — Pending Dec 03, 2025
19252210 COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING THE POSITION OF A HOLE OR A CRACK IN A DRILL STRING AND COMPUTER-READABLE STORAGE MATERIAL Engineering Simulation And Scientific Software Ltda. QUAIM, LAMIA 3676 §101§112 Non-Final OA — Pending Jun 27, 2025
19189953 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. TRAN, ERIC 1629 §103 Non-Final OA 44d overdue Pending Apr 25, 2025
19181025 HIGH TEMPERATURE CORROSION RESISTANT ORGANIC-INORGANIC HYBRID COATINGS Ndsu Research Foundation MCCLURE, CHRISTINA D 1718 §103 Non-Final OA — Pending Apr 16, 2025
19047044 SEMq System for Identification, Determination, Characterization, and/or Quantification of Groundwater or Aquifers G-Strata Spa WALKER, CHRISTOPHER RICHARD 3645 §103 Non-Final OA — Pending Feb 06, 2025
19018493 RETAIL INFORMATION DISPLAY SYSTEM Sagenet LLC GOODMAN, MATTHEW PARKER 3637 §103§112 Non-Final OA — Pending Jan 13, 2025
18858080 CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES Caamtech, Inc. ANDERSON, JAMES D 1629 §102§112 Non-Final OA 44d overdue Pending Oct 18, 2024
18903459 MECHANICAL VAPOR RE-COMPRESSOR HEAT PUMP FOR SEPARATING CO2 FROM WATER VAPOR IN TEMPERATURE-VACUUM SWING ADSORPTION CYCLES Carbon Capture Inc. JONES, CHRISTOPHER P 1776 §112 Non-Final OA — Pending Oct 01, 2024
18898755 CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS Caamtech, Inc. OH, TAYLOR V 1625 §103§112DP Non-Final OA — Pending Sep 27, 2024
18897504 MECHANICAL VAPOR RE-COMPRESSOR HEAT PUMP FOR SEPARATING CO2 FROM WATER VAPOR IN TEMPERATURE-VACUUM SWING ADSORPTION CYCLES Carbon Capture Inc. JONES, CHRISTOPHER P 1776 §112 Non-Final OA — Pending Sep 26, 2024
18844280 INHIBITORS OF FLI1 AND ERG UNIVERSITY OF VIRGINIA PATENT FOUNDATION CHAO, ALLEN 1622 §112 Non-Final OA — Pending Sep 05, 2024
18815064 IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY William Peranteau PACKARD, BENJAMIN J 1616 §102§103§112DP Non-Final OA — Pending Aug 26, 2024
18781180 CRYSTALLINE BIS-MIPROCIN FUMARATE Caamtech, Inc. JACKSON, SHAWQUIA 1626 §112DP Non-Final OA — Pending Jul 23, 2024
18551119 RISK DETERMINATION FOR A PROTHROMBOTIC THROMBOCYTOPAENIA Universitaetsmedizin Greifswald MUI, CHRISTINE T 1797 §101§102§112 Non-Final OA — Pending Apr 22, 2024
18696645 AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL Tecsoil Automacao E Sistemas S.A AWORUNSE, OLUWABUSAYO ADEBANJO 3662 §103§112 Final Rejection 146d overdue Pending Mar 28, 2024
18695584 STABILISING THE HUMAN SPINDLE BY KIFC1/HSET Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. BRETZ, COREY LANE 1635 §101§103§112Other Non-Final OA — Pending Mar 26, 2024
18611908 DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE Vistagen Therapeutics, Inc. HUI, SAN MING R 1627 §101§103 Non-Final OA — Pending Mar 21, 2024
18691986 ASA-COPOLYMER COMPOSITIONS WITH INCREASED TRANSMITTANCE AND PROCESS FOR THE PREPARATION THEREOF Ineos Styrolution Group GmbH SALAMON, PETER A 1759 §103 Non-Final OA — Pending Mar 14, 2024
18688672 METHOD FOR PRODUCING PRESERVED COLLAGENOUS CONNECTIVE TISSUE, COLLAGENOUS CONNECTIVE TISSUE, USES THEREOF AND KIT FOR IMPLANT IN TISSUES Labcor Laboratorios Ltda PENNINGTON, KATIE LEIGH 1634 §103§112DP Non-Final OA — Pending Mar 01, 2024
18683854 3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. MAHLUM, JONATHAN DAVIS 1625 §102§103§112Other Non-Final OA — Pending Feb 15, 2024
18683842 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. WEDDINGTON, KEVIN E 1629 §112Other Non-Final OA — Pending Feb 15, 2024
18683846 N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. BELL, SARA ELIZABETH 1625 §102§112 Non-Final OA — Pending Feb 15, 2024
18407432 WIRELESS HEART TELEMETRY ELECTRODES AND PATIENT MONITORING SYSTEM Jmad Creations, LLC WINAKUR, ERIC FRANK 3791 §102§103§112 Non-Final OA — Pending Jan 08, 2024
18573732 CROSS-LINKING POLYSACCHARIDE WITH FIBROIN AND USES OF THE OBTAINED MATERIAL Merz Pharma GmbH & Co. Kgaa ALDARONDO, DASIA ALI 1647 §102§103 Non-Final OA — Pending Dec 22, 2023
18569507 HIGH CLARITY AND DUCTILE MOLDING COMPOSITION COMPRISING A SMMA COPOLYMER AND A SBC-BLOCK COPOLYMER Ineos Styrolution Group GmbH FOSS, DAVID ROGER 1764 DP Non-Final OA — Pending Dec 12, 2023
18563898 HALLUCINOGEN-FATTY ACID COMBINATION Mindset Pharma Inc. RONEY, CELESTE A 1612 §112 Non-Final OA — Pending Nov 23, 2023
18562066 ACRYLIC RUBBER FOR THERMOPLASTIC MATERIAL WITH GOOD LOW TEMPERATURE IMPACT STRENGTH Ineos Styrolution Group GmbH OLADAPO, TAIWO §103 Final Rejection — Pending Nov 17, 2023
18553868 PSEUDO SOLID PHASE PROTECTING GROUP AND METHODS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES AND OLIGONUCLEOTIDE CONJUGATES BACHEM AG CREWS, JARET JAMES 1691 §103 Final Rejection — Pending Oct 04, 2023
18478427 PRODUCTS AND METHODS FOR MONITORING ADHERENCE TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY Orasure Technologies, Inc. OGUNTADE, ELIZABETH BISOLA 1677 §103§112 Non-Final OA — Pending Sep 29, 2023
18279290 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. AULAKH, CHARANJIT 1621 §112 Final Rejection 5d Pending Aug 29, 2023
18279293 INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Mindset Pharma Inc. SHTERENGARTS, SAMANTHA L 1623 §112 Final Rejection 48d Pending Aug 29, 2023
18360612 PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS Previpharma Consulting GmbH XU, QING 1656 §103§112Other Final Rejection 9d Pending Jul 27, 2023
18262945 CALCIUM HYDROXYAPATITE PARTICLES AND USE THEREOF Merz North America, Inc. MITCHELL, EDWIN COLEMAN 1619 §103 Non-Final OA — Pending Jul 26, 2023
18352677 COMPOSITIONS CONTAINING KRATOM COMPOUNDS Caamtech, Inc. SPAINE, ROBERT FRANKLIN 1655 §101§103Other Non-Final OA 441d overdue Pending Jul 14, 2023
18348866 CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES Ndsu Research Foundation MILLER, BETHANY MACKENZIE 1787 §103§112 Non-Final OA — Pending Jul 07, 2023
18260711 PROTECTED ALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES Caamtech, Inc. CHICKS, ASHLI ARIANA 1626 §102Other Non-Final OA — Pending Jul 07, 2023
18259683 PLANT MATERIAL RECYCLING INOCULANT AND USES THEREOF Imio Technologies, Inc. STEINKE, SEAN JAMES 1619 §101§102§103§112Other Non-Final OA — Pending Jun 28, 2023
18257639 AMANITA MUSCARIA COMPOUNDS Caamtech, Inc. HOFFMAN, SUSAN COE 1655 §101§102§112 Non-Final OA 32d overdue Pending Jun 15, 2023
18265286 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS Mindset Pharma Inc. LEE, CHIHYI NMN 1628 §103§112 Final Rejection 26d overdue Pending Jun 05, 2023
18310945 PREVENTING DECOMPOSITION IN SODIUM CYANIDE COMPOSITIONS Cyanco Corporation NGUYEN, CAM N 1736 §102§112 Non-Final OA — Pending May 02, 2023
18299857 STATIC MAGNETIC FIELD GENERATOR FOR TREATMENT OF CANCER BRAIN & BEYONDS CO., LTD. LANDEEN, BROGAN RANE 3791 §101§103 Final Rejection 2d overdue Pending Apr 13, 2023
18245053 USE OF ACTIVE SUBSTANCES WITH ANTIVIRAL, ANTI MALARIAL, AND/OR MUCOLYTIC PROPERTIES IN THE TREATMENT OF VIRAL LUNG DISEASES INCLUDING COVID-19 BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE Istanbul Universitesi Rektolugu HAGHIGHATIAN, MINA 1616 §102§103§112 Final Rejection — Pending Mar 13, 2023
18178041 COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKIN Merz Pharma GmbH & Co. Kgaa PURDY, KYLE A 1611 §103 Non-Final OA — Pending Mar 03, 2023
18105460 CONJUGATES COMPRISING REVERSIBLE LINKERS AND USES THEREOF Ascendis Pharma A/S JOHNSON, CHRISTOPHER LINDSAY 1691 §112 Final Rejection 34d Pending Feb 03, 2023
18161828 MIXTURES AND FORMULATIONS Camurus AB CONIGLIO, AUDREA JUNE BUCKLEY 1617 §103DP Non-Final OA — Pending Jan 30, 2023
17997600 THERMOPLASTIC POLYMER COMPOSITION WITH REDUCED MIGRATION OF STABILISERS Ineos Styrolution Group GmbH RODD, CHRISTOPHER M 1766 §103 Non-Final OA — Pending Oct 31, 2022
17904404 DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR Istanbul Teknik Universitesi MCANANY, JOHN D 1625 §112 Final Rejection — Pending Aug 17, 2022
17759974 METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD BAHCESEHIR UNIVERSITESI MYERS, CARLA J 1682 §112 Final Rejection 187d overdue Pending Aug 02, 2022
17747557 MEASLES VIRUS ENCODING A TUMOR ANTIGEN Ruprecht-Karls-Universitat Heidelberg NOBLE, MARCIA STEPHENS 1632 §103§112 Non-Final OA 44d overdue Pending May 18, 2022
17776092 APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS BACHEM AG BUNKER, AMY M 1684 §103 Non-Final OA — Pending May 11, 2022
17773241 B-CELL ANTIBODY RECEPTOR AND USE THEREOF Medinet Co., Ltd. SPENCER, ANDREA LYNNE MORRIS 1631 §103 Final Rejection — Pending Apr 29, 2022
17627988 COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS Caamtech, Inc. NOTTINGHAM, KYLE GREGORY 1621 §101§102§103§112 Non-Final OA — Pending Jan 18, 2022
17596832 CONJUGATES OF AN ELECTRON-DONATING NITROGEN OR TERTIARY AMINE COMPRISING COMPOUNDS Ascendis Pharma A/S ELENISTE, PIERRE PAUL 1622 §103§112 Final Rejection 1d overdue Pending Dec 20, 2021
17596833 CONJUGATES OF HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS Ascendis Pharma A/S KATAKAM, SUDHAKAR 1658 §112 Non-Final OA — Pending Dec 20, 2021
17612326 BODY TEMPERATURE DIAGNOSTICS Vivosensmedical GmbH TU, AURELIE H 3791 §101 Final Rejection 29d Pending Nov 18, 2021
17495069 ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES Caamtech, Inc. CORNET, JEAN P 1628 §103§112Other Non-Final OA 54d Pending Oct 06, 2021
17387883 PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS Mindset Pharma Inc. MCDOWELL, BRIAN E 1624 §102 Final Rejection 89d overdue Pending Jul 28, 2021
17422962 PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS Previpharma Consulting GmbH MOSS, NATALIE M 1653 §101§103§112 Non-Final OA 33d Pending Jul 14, 2021
17312249 A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE Henry Johannes Greten FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103§112 Non-Final OA — Pending Jun 09, 2021
17186762 SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF TOPICAL SUBSTANCES Cryoconcepts LP SMITH, PETER DANIEL 3781 §103 Final Rejection 46d overdue Pending Feb 26, 2021
16968146 IMPROVED ALPHA-BETA T PROCESSED CELL PRODUCTION METHOD Medinet Co., Ltd. VIVLEMORE, TRACY ANN 1638 §103 Non-Final OA — Pending Aug 06, 2020
16456773 RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY Ruprecht-Karls Universitaet VIVLEMORE, TRACY ANN 1638 §103§112 Non-Final OA 98d overdue Pending Jun 28, 2019

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month